Topics
chemotherapyTelevision station
HER2Agent
Gastric adenocarcinomaDisease
microsatellite instabilityDisease
programmed death ligand 1Biomolecule
trastuzumabChemical substance
Gastric adenocarcinoma (GAC) is estimated as the fifteenth most common cancer in the USA. Incidence rate has been gradually decreasing, but prognosis remains dismal. For patients with locally advanced GAC (stage > T1B and < T4B), multimodality therapies, such as surgery, chemotherapy, and radiation therapy, are needed. Perioperative chemotherapy or postoperative chemoradiation/chemotherapy is recommended. For metastatic GAC patients, combination of two cytotoxics (platinum compound and fluoropyrimidine) has become a common place in the USA, and when HER2 is positive, trastuzumab is added. When GAC progresses after the first line therapy, additional biomarkers (microsatellite instability and programmed death ligand 1) should be tested ...
Advanced gastric cancer (AGC) is associated with a high mortality rate and, despite multiple new che...
WOS: 000334439200015PubMed ID: 24744580Despite advances in the treatment of gastric cancer, it remai...
The overall 5-year survival of gastric cancer (GC) has change only little in the last decades and it...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Gastric cancer (GC) is one of the most clinically challenging cancers worldwide. Over the past few y...
Gastric cancer is the third most common cause of cancer deaths worldwide. Despite evidence-based rec...
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. ...
Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globa...
Background. Gastric cancer is one of the leading causes of cancer death. With greater understanding ...
Gastric cancer is one of the most common cancers and one of the most frequent causes of cancer-relat...
One of the leading causes of cancer-related deaths worldwide is gastric cancer. In order to choose t...
In recent years, advances of anticancer and supportive therapies have determined a gradual improveme...
Gastric (including gastroesophageal junction) cancer is the third leading cause of cancer-related de...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
Advanced gastric cancer (AGC) is associated with a high mortality rate and, despite multiple new che...
WOS: 000334439200015PubMed ID: 24744580Despite advances in the treatment of gastric cancer, it remai...
The overall 5-year survival of gastric cancer (GC) has change only little in the last decades and it...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Gastric cancer (GC) is one of the most clinically challenging cancers worldwide. Over the past few y...
Gastric cancer is the third most common cause of cancer deaths worldwide. Despite evidence-based rec...
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. ...
Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globa...
Background. Gastric cancer is one of the leading causes of cancer death. With greater understanding ...
Gastric cancer is one of the most common cancers and one of the most frequent causes of cancer-relat...
One of the leading causes of cancer-related deaths worldwide is gastric cancer. In order to choose t...
In recent years, advances of anticancer and supportive therapies have determined a gradual improveme...
Gastric (including gastroesophageal junction) cancer is the third leading cause of cancer-related de...
Gastric cancer is a common malignancy worldwide with a high mortality rate. In advanced gastric canc...
Advanced gastric cancer (AGC) is associated with a high mortality rate and, despite multiple new che...
WOS: 000334439200015PubMed ID: 24744580Despite advances in the treatment of gastric cancer, it remai...
The overall 5-year survival of gastric cancer (GC) has change only little in the last decades and it...
Add to ORKG